INTER AND INTERNATIONAL PUBLICATIONS

  1. Kansu E, Unal S, Karacadağ S, Telatar H, Akkaya S, Kozakoglu H, Dündar S, Batman F, Zileli T. T-lymphocyte subsets in Behcet Disease. In: Lehrer & Barnes (eds), Advances in Behcet Disease. 1986:83.
  1. Unal S, Dundar S, Özerkan K. LIF in Behcet disease. In: Lehrer & Barnes (eds), Advances in Behcet Disease. 1986:103.
  1. Sahin F, Sahin G, Kansu E, Unal S, Duru S, Kansu T, Karacadag S, Batman F, Dündar S, Telatar H, Sayek I, Zileli T. Prostacyclin levels in Behcet disease. In: Lehrer & Barnes (eds), Advances in Behcet Disease. 1986: 155.
  1. Dundar S, Unal S, Sivri B, Müderrisoglu H, Kansu E, Karacadag S, Telatar H, Akkaya S, Kozakoglu H, Kansu T, Zileli T. Behcet disease in Turkish population: analysis of 200 cases. In: Lehrer & Barnes (eds), Advances in Behcet Disease. 1986:219-221.
  1. Unal S, Aydın M, Akin A. Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin. Microbiyol Bul. 1988;22(4):316-21.
  1. Unal S, Aydın M, Dervisoglu AA. An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections. Microbiyol Bul. 1989 Oct;23(4):323-8.
  1. Unal S, Aydin M, Ozaydin N, Akin A. Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections. Microbiyol Bul. 1989 Jul;23(3):231-7.
  1. Akalin HE, Firat M, Unal S, Serin A, Baykal M. Clinical efficacy of ofloxacin single dose/one day treatment with ofloxacin in shigellosis. Rev Infect Dis 1989; 11(Supp 5):1152.
  1. Akalin H, Unal S, Gur D, Baykal M.Ofloxacin in the treatment of brucellosis. Eur. J. Clin. Microbiol. Infect. Dis. 1990:326-328.
  1. Unal S, Akalin H, Gur D, Baykal M. Clinical Efficacy of Ofloxacin in the Treatment of Enteric Fever. Eur. J. Clin. Microbiol. Infect. Dis. 1991; Proceedings, 3rd International Symposium on New Qinolones, pp 306-307.
  1. Unal S, Hoskins JA, Flokowitsch JE, Wu E, Preston DA, Skatrud PL. Detection of Methicillin-Resistant Staphylococci by Using the Polymerase Chain Reaction. J Clin Microbiol. 1992;30:1685-1691.
  1. Uzun O, Akalin HE, Unal S, Demircin M, Yorgancioglu AC, Ugurlu B. Long term oral ciprofloxacin in the treatment of prosthetic valve endocarditis due to Pseudomonas aeruginosa. Scan J Infect Dis. 1992, 24:798-800.
  1. Uzun O, Akalin HE, Hayran M, Unal S. Factors influencing prognosis in Gram-negative bacteremia: evalution of 448 episodes in a Turkish University Hospital. Clin Infec Dis 1992;15:866-873.
  1. Unal S, Flokowitsch J, Mullen L, Preston DA, Nicas TI.In-vitro Synergy and Mechanism of Interaction Between Vancomycin and Ciprofloxacin Against Enterococcal Isolates. Journal of Antimicrobial Chemotherapy 1993;31:711-723.
  1. Gold HS, Unal S, Cercenado, Thauvin-Eliopoulos C, Eliopoulos G, Wennersten CB, and Moellering, Jr, RC. A Gene Conferring Resistance to Vancomycin but Not Teicoplanin in Isolates of Enterococcus faecalis and Enterococcus faecium Demonstrates Homology with vanB, vanA, and vanC Genes of Enterococci. Antimicrobial Agents and Chemotherapy 1993, 37:1604-1609.
  1. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in the treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents and Chemotherapy. 1993; 37:1831-1834.
  1. Unal S. Clinical Features of Human Brucellosis. Mediterranean Journal of Infectious and Parasitic Diseases. September 1993.
  1. Wu C.Y.E, Alborn W.E, Flokowitsch J.E, Hoskins, Unal S, Blaszczak L.C, Preston D.A, and Skatrud P. Site-Directed Mutagenesis of the MecA Gene from a Methicillin-Resistant Strain of Staphylococcus aureus. Journal of Bacteriology 1994;176:443-449.
  1. Unal S, Werner K, DeGirolami P, Barsanti F and Eliopoulos G. Comparisons of the Tests for Detection of Methicillin-Resistant Staphylococcus aureus in a Clinical Microbiology Laboratory. Antimicrobial Agents and Chemotherapy 1994;32:345-347.
  1. Uzun O, Sedghi T, Unal S, Ozsut H, Hayran M, Calangu S, Akalin HE. Comparative efficacies of intravenous ofloxacin once a day and ciprofloxacin twice a day in the treatment of moderate-to-severe infections. Proceedings of 18th International Congress of Chemotherapy 1994; 419.
  1. Akalin HE, Gur D, Unal S, Akova M, Hayran M, Uzun O, Kocagoz S. Antibiotic Resistance Studies in Turkey: Results From OneCenter Over Ten Years. APUA Newsletter 1995;14 (3):1-4.
  1. Gur D, Unal S, Akalin HE.Resistance Patterns in Turkey. Int J Antimicrobial Agents 1995;6 (1):23-26.
  1. Cercenado E, Unal S, Eliopoulos CT, Rubin LG, Isenberg RC, Moellering RC and Eliopoulos GM. Characterization of vancomycin resistance in Enterococcus durans. Journal of Antimicrobial Chemotherapy 1995;36:821-827.
  1. Akova M, Ozcebe O, Gullu I, Unal S, Gur D, Akalin S, Tokgozoglu M, Telatar F, Akalin HE. Efficacy of Sulbactam-Ampicillin for the Treatment of Severe Diabetic Foot Infections. Journal of Chemotherapy 1996;8:284-289
  1. Unal S. Molecular diagnostic methods in pulmonary infections. 1st Mediterranean Congress on Interventional Diagnosis for Thorax Diseases. 25-29 May, 1996, Rhodes, Greece.
  1. Unal S, Hayran M, Tuncer T, Gur D, Uzun O, Akova M, Akalin HE. The Treatment of Enteric Fever with Pefloxacin for 7 Days versus 5 Days: a Randomized Clinical Trial. Antimicrobial Agents and Chemotherapy 1996;40(12):2898-2900.
  1. Alborn WE, Hoskins J, Unal S, Flokowitsch JE, Hayes CA, Dotzlaf JE, Skadrud PL. Cloning and characterization of femA and feB from Staphylococcus epidermidis. Gene 1996;180:177-81.
  1. Uzun O, Kocagoz S, Cetinkaya Y, Arikan S, Unal S. In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against yeast isolates. Antimicrobial Agents and Chemotherapy 1997;41(5):1156-1157.
  1. Topeli A, Unal S, Hayran M, Akalin HE. Septic shock as apredictor of mortality in bacteremia caused by coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 1997;16(6):411-416.
  1. Tuncer S, Tekin MI, Ozen H, Bilen C, Unal S, Remzi D. Detection of Bacillus Calmette-Guerin in the blood by the polymerase chain reaction method of treated bladder cancer patients. J Urol 1997;158:2109:2112.
  1. Yalcin NA, Hayran M, Unal S. Economic analysis of nosocomial infections in a TurkishUniversityHospital. J Chemother 1997;9(6):411-414.
  1. Akcan Y, Tuncer S, Hayran M, Sungur A, Unal S. PCR on disseminated tuberculosis in bone marrow and liver biopsy specimens: correlation to histopathological and clinical diagnosis. Scand J Infect Dis 1997;29:271-274.
  1. Tuncer S, Hayran M, Akan O, Gur D, Akova M, Unal S. Native valve endocarditis with persistent embolization due to Neisseria mucosa. Clinical Microbiology and Infection. 1997;3:137-9.
  1. Kocagoz S, Unal S. The practical use of PCR for rapid detection of methicillin resistance among staphylococcal isolates from Turkish Hospitals. J Clin Microbiol. 1997;35(8):2188-2189.
  1. Gur D, Sener B, Tunckanat F, Kocagoz S, Unal S. In vitro efficacy of antibiotics against three respiratory tract pathogens in a TurkishUniversityHospital. Mediterranean Journal of Infectious and Parasitic Diseases 1997;12:69-72.
  1. Arikan S, Akova M, Hayran M, Ozdemir O, Erman M, Gur D, Unal S. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis. Clin Infect Dis 1998;26:903-908.
  1. Arikan S, Uzun O, Cetinkaya Y, Kocagoz S, Akova M, Unal S. Primary cutaneous aspergillosis in patients with human immunodeficiency virus infection: Report of two cases and review. Clin Infect Dis 1998; 27:641-3.
  1. Arikan S, Tuncer S, Us D, Unal S, Ustacelebi S. Anti-Kp 90 IgA Antibodies in the Diagnosis of Active Tuberculosis. A Preliminary Repot. Turkish Journal of Medicine Science 1998;28:89-92.
  1. Gur D, Kocagoz S, Unal S, Akalin E. Comparative in vitro activity of trovafloxacin against Gram-negative and Gram-positive pathogens. Clinical Microbiology and Infection 1998;4:530-2.
  1. Tuncer S, Erguven S, Kocagoz S, Unal S. Comparison of cytochemical staining, immunofluorescence and PCR for diagnosis of Pneumocytis carinii on sputum samples. Scand J Infect Dis 1998;30:125-8.
  1. Yalcinkaya F, Kamis L, Ozteke O, Gunlusoy B, Yigitbasi O, Unal S. Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer. Int Urol Nephrol. 1998;30(1):41-4
  1. Gur D, Kocagoz S, Akova M, Unal S. Comparison of E Test to Microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrobial Agents and Chemotherapy 1999;43(9):2337.
  1. Meropenem Study group of Turkey,Akova M, Akan H, Korten V, Biberoglu K, Hayran M, Unal S, Kars A, Kansu E. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomized multicentre trial in patients without previous prophylactic antibiotics. Int J Antimicrobial Agents 1999; 13:15-19.
  1. Gunseren F, Mamikoglu L, Ozturk S, Yucesoy M, Biberoglu K, Yulug N, Doganay M, Sumerkan B, Kocagoz S, Unal S. A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. Journal of Antimicrobial Chemotherapy 1999;43:373-378.
  1. Akcan Y, Tuncer S, Unal S, Sokmensuer C, Haznedaroglu CI, Arslan S. Familial Mediterrenean Fever. No role of Mycobacterium tuberculosis in ten patients. Eur J Med. Res. 1999;27:161-164.
  1. Gur D, Kocagoz S, Akova M, Unal S. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrobial Agents and Chemotherapy 1999;43:2337.
  1. The Turkish Antimicrobial resistance Study Group, Pfaller MA, Korten V,

Jones RN, Doern GV, UnalS.Multicenter Evaluation of the Antimicrobial Activity for Seven Broad-Spectrum B-Lactams in Turkey Using the Etest Method. Diagn Microbiology Infectious Diseases 1999:35:65-73.

  1. Aksaray S, Dokuzoguz B, Guvener E, Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S, Gunaydın M, Leblebicioglu H, Esen S, Bayar B, Willke A, Findik D, Tuncer I, Baysal B, Gunseren F, Mamikoglu L. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units eight hospitals in Turkey. Journal of Antimicrobial Chemotherapy 2000 May;45(5):695-9
  1. Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis. 2000 Oct;38(2):101-7.
  1. Aksaray S, Dokuzoguz B, Guvener E, Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S, Gunaydın M, Leblebicioglu H, Esen S, Bayar B, Willke A, Findik D, Tuncer I, Baysal B, Gunseren F, Mamikoglu L. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units eight hospitals in Turkey. Journalof Antimicrobial Chemotherapy 2000 Oct;46(4):649
  1. Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S. Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: comparison to previous three years. J Chemother. 2000 Aug; 12(4):294-8.
  1. Topeli A, Unal S, Akalin HE. Risk factors influencing clinical outcome in Staphylococcus aureus bacteremia in a TurkishUniversityHospital. Int J Antimicrob Agents. 2000;14:57-63I.
  1. Cetinkaya Y, Kocagoz S, Hayran M, Uzun O, Akova M, Gursu G, Unal S. Analysis of a mini-outbreak of methicillin-resisyant Staphylococcus aureus in a surgical ward by using arbitrarily primed-polymerase chain reaction. J Chemother 2000;12:138-144.
  1. Ersoz G, Kaya A, Cayan S, Kandemir O, Ergin A, Cetinkaya Y, Unal S.Urinary Mycobacterium fortuitum infection in an HIV-infected patient. AIDS.2000 Dec 1;14(17):2802-3
  1. Erman M, Akova M, Akan H, KortenV, Ferhanoglu B, Koksal I, Cetinkaya Y, Uzun O, Unal S. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. Scand Journal of Infectious Diseases. 2001; 33(11):827-31,
  1. Aminoglycoside Resistance Study Group.Over U, Gur D, Unal S, Miller GH. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey.Clinical Microbiology & Infection. 2001; 7(9):470-478.
  1. Cetinkaya Y, Akova M, Akalin HE, Ascioglu S, Hayran M, Uzun O, Aksoyek S, Tokgozoglu L, Oto A, Kes S, Pasaoglu I, Unal S. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. International Journal of Antimicrobial Agents. 2001; 18(1):1-7.
  1. Basustaoglu A, Aydogan H, Beyan C, Yalcin A, Unal S. First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey. Emerging Infectious Diseases. 2001; 7(1):160-171.
  1. Gur D, Unal S. Resistance to antimicrobial agents in Mediterranean countries. International Journal of Antimicrobial Agents. 2001; 17(1):21-26.
  1. Sanver A, Topeli A, Cetinkaya Y, Kocagoz S, Unal S. Comparison of closed with open tracheal aspiration system. Clinical Care 2001, 5:P003
  1. Leblebicioglu H, Unal S. The organization of hospital infection control in Turkey. Journal of Hospital Infection. 2002; 51(1):1-6.
  1. Ozkaya Sahin G, Unal S, Hincal F. A Review of Cutaneous Anthrax in Turkey: Experience of HacettepeUniversityMedicalCenter. The ASA Newsletter. 28 June 2002; 02-3:14-16.
  1. Zarakolu P, Soyletir G, Gur D,Unal S. Antimicrobial resistance patterns of respiratory pathogens: a local report from Turkey. Clinical Microbiology and Infection. December 2003;9-12:1257-1258.
  1. Aksoy DY, Turker A, Altundag MK, Abali H, Durusu M, Erman M, Uner A, Sungur AA, Unal S, Uzun O. Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemia. Chemotherapy. 2003 Sep;49 (5):264-6.
  1. Unal S, Masterton R, Goossens H. Bacteraemia in Europe-antimicrobial suspectibility data from the MYSTIC surveillance programme. International Journal of Antimicrobial Agents 2004; 23:155-163.
  1. Zarakolu P, Cakir B, Unal S, Uzun O. P503 Agreement between disc diffusion and E-test methods to assess the carbapenem susceptibily of four Gram-negative nosocomial pathogens. Clinical Microbiology and Infection 2004; 10(6); 593
  1. Zarakolu P, Sahin Hodoglugil NN, Aydin F, Tosun I, Gozalan A, Unal S.Reliability of interpretation of gram-stained vaginal smears by Nugent’s scoring system for diagnosis of bacterial vaginosis. Diagn Microbiol Infect Dis. 2004 Feb;48(2):77-80.
  1. Ozturk MA, Kiraz S, Ertenli I, Uzun O, Calguneri M, Unal S.Rheumatic diseases as causes of fever of unknown origin: an update of classic data. Clin Rheumatol.2004 Feb;23(1):90-1.
  1. Goossens H, Malhotra-Kumar S, Eraksoy H, Unal S, Grabein B, Masterton R, Mendes C, Garcia-Rodriguez JA, Russo G, Jones RN; MYSTIC study group. Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum beta-lactamases. Clinical Microbiology and Infection. 2004 Aug;10(8):760-2.
  1. Aksungur P, Sungur A, Unal S, Iskit B A, Squier A C, Senel S. Chitosan delivery systems for the treatment of oral mucositis:in vitro and in vivo studies. Journal of Controlled Release 2004; 98:269-279.
  1. Topeli A, Harmanci A, Cetinkaya Y, Akdeniz S, Unal S. Comparison of the effect of closed versus open endotracheal suction systems on the development of ventilator-associated pneumonia. Journal of Hospital Infection. 2004; 58:14-19.
  1. Ozkaya Sahin G, Buyukasik Y, Zarakolu P, Tumer A, Sain-Guven G, Unal S.Thallassemia trait in an HIV positve patient. Int Conf AIDS 2004 Jul 11-16;15
  1. Ozkaya Sahin G, Tumer A, Zarakolu P, Sain-Guven G, Yilmaz G, Unal S. Morbidity and mortality characteristics of HIV/AIDS patients admitted to Hacettepe University Adults’ Hospital, Turkey. Inf Conf AIDS 2004 Jul 11-16;15
  1. Filik L, Unal S.Clinical and laboratory features of spontaneous bacterial peritonitis. East Afr Med J 2004 Sep;81(9);474-9
  1. Unal S. Antibiotic consumption. Changing the culture of inappropriate antibiotic prescribing in primary care. Micro Watch 8. Quarter 2 2005. (p19;22)
  1. Ozcakar L, Guven GS, Unal S, Akinci A. Osteoporosis in Turkish HIV/AIDS patients: comparative analysis by dual energy X-ray absorptiometry and digital X-ray radiogrammetry. Osteoporos Int 2005 Apr 12;
  1. Voss A, Allerberger F, Bouza E, Cookson B, Daschner F, Dettenkofer M, Gastmeier P, Gordts B, Heczko P, Jovanovic B, Koller W, Mittermeyer H, Nagy E, RichetH, Unal S, Widmer A: The training curriculum in hospital infection control. Clinical Microbiology and Infection 2005 Apr; 11 Suppl 1:33-5
  1. Bauer W, Schumm-Draeger PM, Koebberling J, Gjoerup T, Garcia Alegria JJ, Ferreira F, Higgens C, Kramer M, Licata G, Mittelman M, O'Hare J, Unal S.EFIM Working Group on Political Issues in Internal Medicine in Europe.Political issues in internal medicine in Europe. Acta Clin Belg. 2005 May-Jun;60(3):157-60
  1. Guven GS, Uzun O, Cakir B, Akova M, Unal S. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001). Support Care Cancer. 2005 Jun 10;
  1. Ergene T, Cok F, Tumer A, Unal S. A controller-study of preventive effects of peer education and single-session lectures on HIV/AIDS knowledge and attitudes among university students in Turkey. AIDS Education and Prevention. 2005 Jun; 17(3):268-78
  1. Metan G, Zarakolu P, Unal S. Rapid detection of antibacterial resistance in emerging Gram-positive cocci. J Hosp Infect. 2005 Oct;61(2):93-9
  1. Ozcakar L, Guven GS, Unal S, Akinci A. Osteoporosis in Turkish HIV/AIDS patients: comparative analysis by dual energy X-ray absorptiometry and digital X-ray radiogrammetry. Osteoporos Int 2005 Nov; 16(11):1363-7
  1. Aksoy DY, Kerimoglu U, Oto A, Erguve S, Arslan S, Unal S, Batman F and Bayraktar Y. Infection with Fasciola hepatica. Clinical Microbiology&Infection November 2005; 11(11): 859
  1. Bauer W, Schumm-Draeger PM, Koebberling J, Gjoerup T, Garcia Alegria JJ, Ferreira F, Higgens C, Kramer M, Licata G, Mittelman M, O’Hare J, Unal S. The EFIM Working Group on Political Issues in Internal Medicine in Europe. Political issues in internal medicine in Europe. A position paper. European Journal of Internal Medicine 2005; 16:214-217.
  1. Odabasi M, Ozkayar N, Ozkara S, Unal S, Denizli A. Pathogenetic antibody removal using magnetically stabilized fluidized bed. Journal of Chromatography B, 2005; 826:50-57
  1. Onal IK, Cankurtaran M, Cakar M, Halil M, Ulger Z, Dogu BB, Uzun O, Unal S, Ariogul S. Fever of unknown origin: What is remarkable in the elderly in a developing country? J Infect. 2005 Oct 24;
  1. Unal S, Garcia-Rodriguez JA.Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.Diagn Microbiol Infect Dis. 2005 Dec;53(4):265-71
  1. Guven GS, Uzun O, Cakir B, Akova M, Unal S. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001). Support Care Cancer. 2006 Jan;14(1):52-5. Epub 2005 Jun 10;
  1. Kurne A, Ozkaya G, Karlioguz K, Shorbagi A, Ustacelebi S, Karabudak R, Unal S. The colorful clinical spectrum of cerebral toxoplasmosis in five HIV positive cases: what comes out of Pandora's box?Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):85-92
  1. Zarakolu P, Sakizligil B, Unal S. Antimicrobial resistance of Neisseria gonorrhoeae strains isolated from sex workers in Ankara. Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):69-73
  1. Dolapci I, Tekeli A, Koyuncu E, Sain Guven G, Unal S.Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in human immunodeficiency virus positive men without urethritis symptoms. Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):63-7
  1. Aksoy DY, Kerimoglu U, Oto A, Erguven S, Arslan S, Unal S, Batman F, Bayraktar Y. Fasciola hepatica infection: Clinical and computerized tomographic findings of ten patients.Turk J Gastroenterol. 2006 Mar;17(1):40-45.
  1. Tanriover MD, Guven GS, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiol Infect. 2006 Apr;134(2):315-22.
  1. Guven GS, Uzun O, Cakir B, Akova M, Unal S.Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001).Support Care Cancer. 2006 Jan; 14(1):52-5. Epub 2005 Jun 10.
  1. Unal S. Turkey and the Avian Flu. Who has won the battle.ESCMID News No 1.2006- (p18-19).
  1. Ozkaya G, Kurne A, Unal S, Oguz KK, Karabudak R, Saygi S. Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of “AIDS-toxoplasmosis complex” Epilepsy Behav, 2006 May 11.
  1. Onal IK, Bayraktar Y, Unal S.Paradoxical deterioration during the course of antituberculous treatment. J Natl Med Assoc. 2006 Jun;98(6):954-5
  1. Ozyurek E, Ergunay K, Kuskonmaz B, Unal S, Cetin M, Ustacelebi S, Gurgey A, Gumruk F. Transfusion-transmitted virus prevalence in Turkish patients with thalassemia.Pediatr Hematol Oncol. 2006 Jun;23(4):347-53
  1. Zarakolu P, Hascelik G, Unal S. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in HacettepeUniversityAdultHospital (2000-2004)], Mikrobiyol Bul. 2006 Jul;40(3):147-54
  1. Zarakolu P, Unal S.Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.J Chemother. 2006 Oct;18(5):565-6.
  1. Ozkaya G, Yildirim T, Aydin K, Ergüven S, Unal S.A plasmodium alciparum malaria case originated from Mozambique: clues for the diagnosis and therapy. Mikrobiyol Bul. 2006 Oct;40(4):407-11.
  1. Dizdar O, Karadağ O, Kalyoncu U, Kurt M, Ulger Z, Sardan YC, Unal S.Appropriate utilization of hospital beds in internal medicine: evaluation in a tertiary care hospital.J Eval Clin Pract. 2007 Jun;13(3):408-11
YURTİÇİ YAYINLAR
  1. Sözen T, Ünal S. Verapamilin serum prolaktin düzeyleri üzerine etkisi. Türkiye Klinikleri Tıp Bilimleri Araştırma Dergisi 1983; 1: 59- 63.
  1. Dündar S, Ünal S, Özerkan K. Behçet hastalığında lökosit inhibisyon faktörü. Türkiye Klinikleri 1985; 5: 432-434.
  1. Ünal S, Arıoğul S. ANA-negatif Sistemik Lupus Eritematosus: Iki olgu nedeniyle. GATA Bülteni. 1985; 27: 767-770.
  1. Sözen T, Ünal S. Lityumun diabetiklerde glukoz toleransı ve insülin düzeyleri üzerine etkisi. Doğa Bilim Dergisi 1985; 9: 37-45.
  1. Gedik O, Sözen T, Ünal S. Lityum karbonata bağlı tirotoksikosis. Iç Hastalıkları Dergisi 1986; 1: 23-24.
  1. Ünal S, Akalın HE, Baykal M. Cefoperazonun gentamisin-dirençli gram- negatif bakterilerle gelişen infeksiyonlarda klinik etkinliği. Iç Hastalıkları Dergisi 1987; 4: 175-178.
  1. Kansu E, Ünal S, Batman F, Karacadağ Ş, Dündar S, Akkaya S, Kozakoğlu H, Kansu T, Zileli T. Behçet hastalığında lenfosit alt gruplarının değerlendirilmesi. Deri Hastalıkları ve Frengi Arşivi 1987; 21(1): 7-12.
  1. Ünal S, Aydın M, Akın A. Bazı gram-negatif bakterilerin TMP-SMX ve ofloxacin'e duyarlılıkları. Mikrobiyoloji Bülteni 1988; 22(4): 316-321.
  1. Ünal S, Akmansu H. Üst solunum yolu enfeksiyonlarında tanı ve tedavi. Türk Ilaç ve Tedavi Dergisi 1989; 2(3): 157-164.
  1. Ünal S, Akalın HE. Antibiotik kullanımının temel ilkeleri. Türk Ilaç ve Tedavi Dergisi 1989; 2(4): 206-210.
  1. Ünal S, Aydın M, Özaydın N, Dervişoğlu Akın A.